Terns Pharma Stock (NASDAQ: TERN) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 202.000 / 945.128K |
Day Range | - - - |
52 Wk Range | 3.260 - 13.030 |
Market Cap | $404.232M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 61 |
Short Interest | 7.87% |
Days to Cover | 6.72 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Terns Pharma (NASDAQ: TERN) through any online brokerage.
Other companies in Terns Pharma’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Theravance Biopharma (NASDAQ:TBPH), Zevra Therapeutics (NASDAQ:ZVRA), Third Harmonic Bio (NASDAQ:THRD) and GH Research (NASDAQ:GHRS).
The latest price target for Terns Pharma (NASDAQ: TERN) was reported by HC Wainwright & Co. on Tuesday, May 14, 2024. The analyst firm set a price target for 5.50 expecting TERN to fall to within 12 months (a possible -12.00% downside). 21 analyst firms have reported ratings in the last year.
The stock price for Terns Pharma (NASDAQ: TERN) is $6.25 last updated Today at May 21, 2024 at 8:14 AM EDT.
There are no upcoming dividends for Terns Pharma.
Terns Pharma’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
There is no upcoming split for Terns Pharma.
Terns Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.